RAPGEF6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.538000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.434600E-01
Normal-vs-Stage2
4.565800E-01
Normal-vs-Stage3
2.950400E-01
Normal-vs-Stage4
5.962800E-01
Stage1-vs-Stage2
4.879800E-01
Stage1-vs-Stage3
3.297600E-02
Stage1-vs-Stage4
5.986800E-01
Stage2-vs-Stage3
1.073430E-01
Stage2-vs-Stage4
2.251000E-01
Stage3-vs-Stage4
6.604000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.510600E-01
Normal-vs-AfricanAmerican
4.892200E-01
Normal-vs-Asian
3.807000E-01
Caucasian-vs-AfricanAmerican
1.844220E-01
Caucasian-vs-Asian
2.756000E-01
AfricanAmerican-vs-Asian
1.478210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.375800E-01
Normal-vs-Female
4.760800E-01
Male-vs-Female
3.425200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.605000E-01
Normal-vs-Age(41-60Yrs)
5.192400E-01
Normal-vs-Age(61-80Yrs)
4.345000E-01
Normal-vs-Age(81-100Yrs)
3.598600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.916200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.958800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.386820E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.415700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.960300E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.140300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.328000E-01
Normal-vs-Daily Drinker
3.607000E-01
Normal-vs-Weekly Drinker
3.899400E-01
Normal-vs-Occasional Drinker
4.604800E-01
Normal-vs-Social Drinker
5.270600E-01
Non Drinker-vs-Daily Drinker
1.651610E-01
Non Drinker-vs-Weekly Drinker
5.324600E-01
Non Drinker-vs-Occasional Drinker
6.990000E-01
Non Drinker-vs-Social Drinker
3.281400E-01
Daily Drinker-vs-Weekly Drinker
5.904400E-01
Daily Drinker-vs-Occasional Drinker
7.252100E-02
Daily Drinker-vs-Social Drinker
6.801600E-02
Weekly Drinker-vs-Occasional Drinker
3.133200E-01
Weekly Drinker-vs-Social Drinker
1.810150E-01
Occasional Drinker-vs-Social Drinker
5.299000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.647620E-01
Normal-vs-Grade 2
4.827500E-02
Normal-vs-Grade 3
1.602170E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.402200E-01
Grade 1-vs-Grade 3
7.613200E-01
Grade 1-vs-Grade 4
1.647620E-01
Grade 2-vs-Grade 3
7.811200E-01
Grade 2-vs-Grade 4
4.827500E-02
Grade 3-vs-Grade 4
1.602170E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.479800E-01
Normal-vs-NonDiabetic
4.172600E-01
Diabetic-vs-NonDiabetic
4.539000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.652200E-01
Normal-vs-NoPancreatitis
4.388800E-01
Pancreatitis-vs-NoPancreatitis
4.446200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.593600E-01
Normal-vs-N1
4.544200E-01
N0-vs-N1
9.499400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.452400E-01
Normal-vs-TP53-NonMutant
5.708000E-01
TP53-Mutant-vs-TP53-NonMutant
3.799900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
